drugset / Trial / NCT03596177

A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus

NCT03596177

Phase 2 Completed 28 enrolled MedImmune LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

An exploratory study to evaluate the effect of MEDI0382 on energy balance in overweight and obese participants with type 2 diabetes mellitus

Timeline

Start
2018-09-26
Primary completion
2019-12-22
Completion
2019-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Cotadutide Peptide 300 ug Subcutaneous